Molecular targeting agents for multiple myeloma
Fujii, S.; Abe, M.
Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 8): 518-523
2012
ISSN/ISBN: 0047-1852 PMID: 23513894 Document Number: 663744
Document emailed within 1 workday
Related Documents
Tricot, G.J. 2007: What is the significance of molecular remission in multiple myeloma? Clinical Advances in Hematology and Oncology: H&o 5(2): 91-95Rupa-Matysek, J.; Gil, L.; Komarnicki, M.ła. 2011: Thrombotic complications following the treatment of multiple myeloma with new agents Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 31(186): 372-377
Weber, D.M. 2003: Strategies in treating newly diagnosed or untreated multiple myeloma patients. from the Multiple Myeloma Research Foundation Oncology 17(6): 765-767
Matzner, Y.; Benbassat, J.; Polliack, A. 1977: Prognostic factors and the effect of alkylating agents on survival in multiple myeloma. a review of 80 patients Israel Journal of Medical Sciences 13(8): 797-807
Iakupova, E.V.; Grinchuk, O.V.; Kalimullina, D.Kh.; Bakirov, B.A.; Galimova, R.R.; Makarova, O.V.; Khusnutdinova, E.K.; Viktorova, T.V. 2003: Molecular genetic analysis of the interleukin 6 and tumor necrosis factor alpha gene polymorphisms in multiple myeloma Molekuliarnaia Biologiia 37(3): 420-424
Pasqualetti, P.; Casale, R.; Collacciani, A.; Colantonio, D. 1989: Evaluation of a morphologic staging method (myeloma progression score) in multiple myeloma Medicina 9(3): 280-282
Barlogie, B.; Alexanian, R. 1989: Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma Cancer Research 49(24 Pt 1): 7172-7175
Demetter, P.; Maréchal, R.; Verset, L.; Salmon, I.; Bachet, J.-B.; Van Laethem, J.L. 2012: Molecular changes in pancreatic cancer: implications for molecular targeting therapy Acta Gastro-Enterologica Belgica 75(2): 210-214
Wu, M-Jei.; Fang, H-Chang.; Chang, T-Yuan.; Lo, Y-Shing.; Chung, H-Min. 2002: Multiple myeloma with myeloma nephropathy in a patient with Hashimoto's thyroiditis Journal of the Formosan Medical Association 101(6): 421-424
Tabe, Y. 2009: Molecular diagnosis of and molecular targeting therapy for leukemia Rinsho Byori. Japanese Journal of Clinical Pathology 57(2): 137-145
García Laraña, J.; Díaz Mediavilla, J.; Martínez, R.; Lahuerta, J.J.; Alegre, A.; Odriozola, J.; Sureda, A.; San Miguel, J.; De la Rubia, J.; Escudero, A.; Conde, E.; Bladé, J.; Cabrera, R.; Gastearena, J.; Besalduch, J.; Vidal, M.J.; Hernández, F.; Rifon, J.; Leon, A.; Mataix, R.; Parody, R.; Moraleda, J.M.; Solano, C.; de Pablos, J.M.; Sánchez, J.J. 1997: Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma Sangre 42(Suppl 1): 38-41
Teunissen, L.L.; Notermans, N.C. 1998: The risk of Kahler disease (multiple myeloma) in patients with a paraproteinemia: myeloma risk score, developed in the region of the Integral Cancer Center, West Nederlands Tijdschrift Voor Geneeskunde 142(43): 2374-2375
Takahashi, T.; Makiguchi, Y.; Hinoda, Y.; Kakiuchi, H.; Nakagawa, N.; Imai, K.; Yachi, A. 1994: Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient Journal of Immunology 153(5): 2102-2109
Uemura, H. 2012: Era of molecular targeting therapy in RCC Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 8): 480-485
Nishioka, Y. 2013: I. Molecular targeting therapy and immunotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(8): 1004-1008
Hara, M.; Kinoshita, M. 2012: Molecular targeting therapy of dyslipidemia Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 8): 618-622
Weber, W.A.; Haubner, R.; Vabuliene, E.; Kuhnast, B.; Wester, H.J.; Schwaiger, M. 2001: Tumor angiogenesis targeting using imaging agents Quarterly Journal of Nuclear Medicine: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology 45(2): 179-182
Nakano, H. 1991: Antitumor agents targeting mammalian topoisomerases Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(10): 1550-1555
Mima, T.; Nakashima, Y.; Hanba, Y.; Ohya, M.; Negi, S.; Shigematsu, T. 2012: Molecular targeting therapy in rheumatoid arthritis Nihon Jinzo Gakkai Shi 54(5): 603-609
Siemann, D.W.; Horsman, M.R. 2002: Enhancement of radiation therapy by vascular targeting agents Current Opinion in Investigational Drugs 3(11): 1660-1665